Minimal clinically important differences in health-related quality of life after total hip or knee replacement: A systematic review
- PMID: 23610674
- PMCID: PMC3626243
- DOI: 10.1302/2046-3758.15.2000065
Minimal clinically important differences in health-related quality of life after total hip or knee replacement: A systematic review
Abstract
Objectives: We aimed first to summarise minimal clinically important differences (MCIDs) after total hip (THR) or knee replacement (TKR) in health-related quality of life (HRQoL), measured using the Short-Form 36 (SF-36). Secondly, we aimed to improve the precision of MCID estimates by means of meta-analysis.
Methods: We conducted a systematic review of English and non-English articles using MEDLINE, the Cochrane Controlled Trials Register (1960-2011), EMBASE (1991-2011), Web of Science, Academic Search Premier and Science Direct. Bibliographies of included studies were searched in order to find additional studies. Search terms included MCID or minimal clinically important change, THR or TKR and Short-Form 36. We included longitudinal studies that estimated MCID of SF-36 after THR or TKR.
Results: THREE STUDIES MET OUR INCLUSION CRITERIA, DESCRIBING A DISTINCT STUDY POPULATION: primary THR, primary TKR and revision THR. No synthesis of study results can be given.
Conclusions: Although we found MCIDs in HRQoL after THR or TKR have limited precision and are not validated using external criteria, these are still the best known estimates of MCIDs in HRQoL after THR and TKR to date. We therefore advise these MCIDs to be used as absolute thresholds, but with caution.
Keywords: Health-related quality of life; Minimal clinically important differences; SF-36; Systematic review; Total hip replacement; Total knee replacement.
Conflict of interest statement
Figures



References
-
- Harris WH, Sledge CB. Total hip and total knee replacement (1). N Engl J Med 1990;323:725–731 - PubMed
-
- Jaeschke R, Singer J, Guyatt GH. Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials 1989;10:407–415 - PubMed
-
- King MT. A point of minimal important difference (MID): a critique of terminology and methods. Expert Rev Pharmacoecon Outcomes Res 2011;11:171–184 - PubMed
-
- Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR; Clinical Significance Consensus Meeting Group. Methods to explain the clinical significance of health status measures. Mayo Clin Proc 2002;77:371–383 - PubMed
LinkOut - more resources
Full Text Sources